Patent directory · USPTO A61K / A61P
Patents matching “Regents of the University of Minnesota”
446 pharma patents match "Regents of the University of Minnesota" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 446 pharmaceutical patents matching "Regents of the University of Minnesota" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12426594
Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
granted -
US 12414983
CD200AR ligands for cancer immunotherapy
granted -
US 12383534
Methods for treating cancer
granted -
US 12384830
Compositions and methods for improving immunotherapy
granted -
US 12383655
Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane
granted -
US 12370256
Activation of resident memory T cells for the treatment of cancer
granted -
US 12343397
Drug-resistant immune cells and methods of use thereof
granted -
US 12329457
Hyperspectral imaging for early detection of Alzheimer's disease
granted -
US 12319737
NK engager molecules and methods of use thereof
granted -
US 12295974
Compositions and methods for transplantation of colon microbiota
granted -
US 12295929
Intravenous baclofen formulations and treatment methods
granted -
US 12281327
Lymphohematopoietic engineering using CAS9 base editors
granted -
US 12281105
Contraceptive compounds and methods
granted -
US 12274759
Affibody proteins specific for B7-H3 (CD276)
granted -
US 12269887
Anti-canine CD16 polypeptides, anti-canine CD64 polypeptides, compositions including same, and methods of using
granted -
US 12270050
Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using
granted -
US 12233073
Skin care formulations and skin cancer treatment
granted -
US 12234480
Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
granted -
US 12221612
Plants having increased oil quality
granted -
US 12221629
Methods for producing fibroadipogenic progenitor cells
granted -
US 12209140
Therapeutics for the treatment of glaucoma
granted -
US 12186349
Compositions and methods for C. difficile treatment
granted -
US 12171785
Pluripotent cells derived from bone marrow and methods for isolation
granted -
US 12161755
Sustained release device for treatment of Parkinson's disease and other disorders
granted